These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3556610

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR, Chetrite GS.
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells.
    Yde CW, Clausen MP, Bennetzen MV, Lykkesfeldt AE, Mouritsen OG, Guerra B.
    Anticancer Drugs; 2009 Sep; 20(8):723-35. PubMed ID: 19584708
    [Abstract] [Full Text] [Related]

  • 27. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Sep; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 28. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
    Murphy CS, Langan-Fahey SM, McCague R, Jordan VC.
    Mol Pharmacol; 1990 Nov; 38(5):737-43. PubMed ID: 2233701
    [Abstract] [Full Text] [Related]

  • 29. Metabolism of tamoxifen and its uterotrophic activity.
    Lyman SD, Jordan VC.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2787-94. PubMed ID: 4015715
    [Abstract] [Full Text] [Related]

  • 30. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Campen CA, Jordan VC, Gorski J.
    Endocrinology; 1985 Jun 01; 116(6):2327-36. PubMed ID: 3996316
    [Abstract] [Full Text] [Related]

  • 31. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM, Langan-Fahey SM, Parker CJ, McCague R, Jordan VC.
    J Natl Cancer Inst; 1993 May 19; 85(10):806-12. PubMed ID: 8487325
    [Abstract] [Full Text] [Related]

  • 32. The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.
    Osborne CK, Jarman M, McCague R, Coronado EB, Hilsenbeck SG, Wakeling AE.
    Cancer Chemother Pharmacol; 1994 May 19; 34(2):89-95. PubMed ID: 8194171
    [Abstract] [Full Text] [Related]

  • 33. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen].
    Borgna JL, Rochefort H.
    C R Seances Acad Sci D; 1979 Dec 10; 289(15):1141-4. PubMed ID: 121266
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.
    Borgna JL, Rochefort H.
    J Biol Chem; 1981 Jan 25; 256(2):859-68. PubMed ID: 7451477
    [Abstract] [Full Text] [Related]

  • 36. Modification of the basic side chain in tamoxifen: effects on microsomal metabolism and in vitro biological activity.
    Foster AB, McCague R, Seago A, Leclercq G, Stoessel S, Roy F.
    Anticancer Drug Des; 1986 Nov 25; 1(3):245-57. PubMed ID: 3450297
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.
    Levenson AS, MacGregor Schafer JI, Bentrem DJ, Pease KM, Jordan VC.
    J Steroid Biochem Mol Biol; 2001 Nov 25; 76(1-5):61-70. PubMed ID: 11384864
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ligand interaction at the estrogen receptor to program antiestrogen action: a study with nonsteroidal compounds in vitro.
    Jordan VC, Koch R, Langan S, McCague R.
    Endocrinology; 1988 Apr 25; 122(4):1449-54. PubMed ID: 3345720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.